Vivera Pharmaceuticals Congratulates Partner Clinical Research Organization, Parexel International, on $8.5 Billion Acquisition by Goldman Sachs

NEWPORT BEACH, Calif.: NEWPORT BEACH, Calif., July 6, 2021 /PRNewswire/ -- Vivera Pharmaceuticals, Inc., congratulates its clinical research partner, Parexel International, on its $8.5 billion acquisition. The EQT IX fund and the private equity business within Goldman Sachs Asset Management recently agreed to purchase the clinical research organization and biopharmaceutical...

Click to view original post